About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Pediatric Cancer Biomarkers Market Size, Trends & Growth | By 2033
Pediatric Cancer Biomarkers Market

Pediatric Cancer Biomarkers Market Size, Share & Trends Analysis Report By Indication (Lymphoma, Neuroblastoma, Leukemia, CNS Tumors, Others), By Biomarker (Neuron-Specific enolase (NSE), Alpha-Fetoprotien (AFP), ALK (Anaplastic lymphoma receptor tyrosine kinase gene), CD19, CD20, CD22, Others), By End-User (Hospitals, Oncology Centers, Research Institutions, Diagnostic Laboratories) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH56788DR
Last Updated : Jan 09, 2025
Author : Debashree Bora
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Pediatric Cancer Biomarkers Market, By Indication (2021-2033)
    1. Lymphoma
    2. Neuroblastoma
    3. Leukemia
    4. CNS Tumors
    5. Others
  2. Pediatric Cancer Biomarkers Market, By Biomarker (2021-2033)
    1. Neuron-Specific enolase (NSE)
    2. Alpha-Fetoprotien (AFP)
    3. ALK (Anaplastic lymphoma receptor tyrosine kinase gene)
    4. CD19, CD20, CD22
    5. Others
  3. Pediatric Cancer Biomarkers Market, By End-User (2021-2033)
    1. Hospitals
    2. Oncology Centers
    3. Research Institutions
    4. Diagnostic Laboratories
    1. North America
      1. North America Pediatric Cancer Biomarkers Market, By Indication
        1. Lymphoma
          1. Neuroblastoma
            1. Leukemia
              1. CNS Tumors
                1. Others
                2. North America Pediatric Cancer Biomarkers Market, By Biomarker
                  1. Neuron-Specific enolase (NSE)
                    1. Alpha-Fetoprotien (AFP)
                      1. ALK (Anaplastic lymphoma receptor tyrosine kinase gene)
                        1. CD19, CD20, CD22
                          1. Others
                          2. North America Pediatric Cancer Biomarkers Market, By End-User
                            1. Hospitals
                              1. Oncology Centers
                                1. Research Institutions
                                  1. Diagnostic Laboratories
                                  2. U.S.
                                    1. U.S. Pediatric Cancer Biomarkers Market, By Indication
                                      1. Lymphoma
                                        1. Neuroblastoma
                                          1. Leukemia
                                            1. CNS Tumors
                                              1. Others
                                              2. U.S. Pediatric Cancer Biomarkers Market, By Biomarker
                                                1. Neuron-Specific enolase (NSE)
                                                  1. Alpha-Fetoprotien (AFP)
                                                    1. ALK (Anaplastic lymphoma receptor tyrosine kinase gene)
                                                      1. CD19, CD20, CD22
                                                        1. Others
                                                        2. U.S. Pediatric Cancer Biomarkers Market, By End-User
                                                          1. Hospitals
                                                            1. Oncology Centers
                                                              1. Research Institutions
                                                                1. Diagnostic Laboratories
                                                              2. Canada
                                                            2. Europe
                                                              1. Europe Pediatric Cancer Biomarkers Market, By Indication
                                                                1. Lymphoma
                                                                  1. Neuroblastoma
                                                                    1. Leukemia
                                                                      1. CNS Tumors
                                                                        1. Others
                                                                        2. Europe Pediatric Cancer Biomarkers Market, By Biomarker
                                                                          1. Neuron-Specific enolase (NSE)
                                                                            1. Alpha-Fetoprotien (AFP)
                                                                              1. ALK (Anaplastic lymphoma receptor tyrosine kinase gene)
                                                                                1. CD19, CD20, CD22
                                                                                  1. Others
                                                                                  2. Europe Pediatric Cancer Biomarkers Market, By End-User
                                                                                    1. Hospitals
                                                                                      1. Oncology Centers
                                                                                        1. Research Institutions
                                                                                          1. Diagnostic Laboratories
                                                                                          2. U.K.
                                                                                            1. U.K. Pediatric Cancer Biomarkers Market, By Indication
                                                                                              1. Lymphoma
                                                                                                1. Neuroblastoma
                                                                                                  1. Leukemia
                                                                                                    1. CNS Tumors
                                                                                                      1. Others
                                                                                                      2. U.K. Pediatric Cancer Biomarkers Market, By Biomarker
                                                                                                        1. Neuron-Specific enolase (NSE)
                                                                                                          1. Alpha-Fetoprotien (AFP)
                                                                                                            1. ALK (Anaplastic lymphoma receptor tyrosine kinase gene)
                                                                                                              1. CD19, CD20, CD22
                                                                                                                1. Others
                                                                                                                2. U.K. Pediatric Cancer Biomarkers Market, By End-User
                                                                                                                  1. Hospitals
                                                                                                                    1. Oncology Centers
                                                                                                                      1. Research Institutions
                                                                                                                        1. Diagnostic Laboratories
                                                                                                                      2. Germany
                                                                                                                      3. France
                                                                                                                      4. Spain
                                                                                                                      5. Italy
                                                                                                                      6. Russia
                                                                                                                      7. Nordic
                                                                                                                      8. Benelux
                                                                                                                      9. Rest of Europe
                                                                                                                    2. APAC
                                                                                                                      1. APAC Pediatric Cancer Biomarkers Market, By Indication
                                                                                                                        1. Lymphoma
                                                                                                                          1. Neuroblastoma
                                                                                                                            1. Leukemia
                                                                                                                              1. CNS Tumors
                                                                                                                                1. Others
                                                                                                                                2. APAC Pediatric Cancer Biomarkers Market, By Biomarker
                                                                                                                                  1. Neuron-Specific enolase (NSE)
                                                                                                                                    1. Alpha-Fetoprotien (AFP)
                                                                                                                                      1. ALK (Anaplastic lymphoma receptor tyrosine kinase gene)
                                                                                                                                        1. CD19, CD20, CD22
                                                                                                                                          1. Others
                                                                                                                                          2. APAC Pediatric Cancer Biomarkers Market, By End-User
                                                                                                                                            1. Hospitals
                                                                                                                                              1. Oncology Centers
                                                                                                                                                1. Research Institutions
                                                                                                                                                  1. Diagnostic Laboratories
                                                                                                                                                  2. China
                                                                                                                                                    1. China Pediatric Cancer Biomarkers Market, By Indication
                                                                                                                                                      1. Lymphoma
                                                                                                                                                        1. Neuroblastoma
                                                                                                                                                          1. Leukemia
                                                                                                                                                            1. CNS Tumors
                                                                                                                                                              1. Others
                                                                                                                                                              2. China Pediatric Cancer Biomarkers Market, By Biomarker
                                                                                                                                                                1. Neuron-Specific enolase (NSE)
                                                                                                                                                                  1. Alpha-Fetoprotien (AFP)
                                                                                                                                                                    1. ALK (Anaplastic lymphoma receptor tyrosine kinase gene)
                                                                                                                                                                      1. CD19, CD20, CD22
                                                                                                                                                                        1. Others
                                                                                                                                                                        2. China Pediatric Cancer Biomarkers Market, By End-User
                                                                                                                                                                          1. Hospitals
                                                                                                                                                                            1. Oncology Centers
                                                                                                                                                                              1. Research Institutions
                                                                                                                                                                                1. Diagnostic Laboratories
                                                                                                                                                                              2. Korea
                                                                                                                                                                              3. Japan
                                                                                                                                                                              4. India
                                                                                                                                                                              5. Australia
                                                                                                                                                                              6. Taiwan
                                                                                                                                                                              7. South East Asia
                                                                                                                                                                              8. Rest of Asia-Pacific
                                                                                                                                                                            2. Middle East and Africa
                                                                                                                                                                              1. Middle East and Africa Pediatric Cancer Biomarkers Market, By Indication
                                                                                                                                                                                1. Lymphoma
                                                                                                                                                                                  1. Neuroblastoma
                                                                                                                                                                                    1. Leukemia
                                                                                                                                                                                      1. CNS Tumors
                                                                                                                                                                                        1. Others
                                                                                                                                                                                        2. Middle East and Africa Pediatric Cancer Biomarkers Market, By Biomarker
                                                                                                                                                                                          1. Neuron-Specific enolase (NSE)
                                                                                                                                                                                            1. Alpha-Fetoprotien (AFP)
                                                                                                                                                                                              1. ALK (Anaplastic lymphoma receptor tyrosine kinase gene)
                                                                                                                                                                                                1. CD19, CD20, CD22
                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                  2. Middle East and Africa Pediatric Cancer Biomarkers Market, By End-User
                                                                                                                                                                                                    1. Hospitals
                                                                                                                                                                                                      1. Oncology Centers
                                                                                                                                                                                                        1. Research Institutions
                                                                                                                                                                                                          1. Diagnostic Laboratories
                                                                                                                                                                                                          2. UAE
                                                                                                                                                                                                            1. UAE Pediatric Cancer Biomarkers Market, By Indication
                                                                                                                                                                                                              1. Lymphoma
                                                                                                                                                                                                                1. Neuroblastoma
                                                                                                                                                                                                                  1. Leukemia
                                                                                                                                                                                                                    1. CNS Tumors
                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                      2. UAE Pediatric Cancer Biomarkers Market, By Biomarker
                                                                                                                                                                                                                        1. Neuron-Specific enolase (NSE)
                                                                                                                                                                                                                          1. Alpha-Fetoprotien (AFP)
                                                                                                                                                                                                                            1. ALK (Anaplastic lymphoma receptor tyrosine kinase gene)
                                                                                                                                                                                                                              1. CD19, CD20, CD22
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                2. UAE Pediatric Cancer Biomarkers Market, By End-User
                                                                                                                                                                                                                                  1. Hospitals
                                                                                                                                                                                                                                    1. Oncology Centers
                                                                                                                                                                                                                                      1. Research Institutions
                                                                                                                                                                                                                                        1. Diagnostic Laboratories
                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                      1. LATAM Pediatric Cancer Biomarkers Market, By Indication
                                                                                                                                                                                                                                        1. Lymphoma
                                                                                                                                                                                                                                          1. Neuroblastoma
                                                                                                                                                                                                                                            1. Leukemia
                                                                                                                                                                                                                                              1. CNS Tumors
                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                2. LATAM Pediatric Cancer Biomarkers Market, By Biomarker
                                                                                                                                                                                                                                                  1. Neuron-Specific enolase (NSE)
                                                                                                                                                                                                                                                    1. Alpha-Fetoprotien (AFP)
                                                                                                                                                                                                                                                      1. ALK (Anaplastic lymphoma receptor tyrosine kinase gene)
                                                                                                                                                                                                                                                        1. CD19, CD20, CD22
                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                          2. LATAM Pediatric Cancer Biomarkers Market, By End-User
                                                                                                                                                                                                                                                            1. Hospitals
                                                                                                                                                                                                                                                              1. Oncology Centers
                                                                                                                                                                                                                                                                1. Research Institutions
                                                                                                                                                                                                                                                                  1. Diagnostic Laboratories
                                                                                                                                                                                                                                                                  2. Brazil
                                                                                                                                                                                                                                                                    1. Brazil Pediatric Cancer Biomarkers Market, By Indication
                                                                                                                                                                                                                                                                      1. Lymphoma
                                                                                                                                                                                                                                                                        1. Neuroblastoma
                                                                                                                                                                                                                                                                          1. Leukemia
                                                                                                                                                                                                                                                                            1. CNS Tumors
                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                              2. Brazil Pediatric Cancer Biomarkers Market, By Biomarker
                                                                                                                                                                                                                                                                                1. Neuron-Specific enolase (NSE)
                                                                                                                                                                                                                                                                                  1. Alpha-Fetoprotien (AFP)
                                                                                                                                                                                                                                                                                    1. ALK (Anaplastic lymphoma receptor tyrosine kinase gene)
                                                                                                                                                                                                                                                                                      1. CD19, CD20, CD22
                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                        2. Brazil Pediatric Cancer Biomarkers Market, By End-User
                                                                                                                                                                                                                                                                                          1. Hospitals
                                                                                                                                                                                                                                                                                            1. Oncology Centers
                                                                                                                                                                                                                                                                                              1. Research Institutions
                                                                                                                                                                                                                                                                                                1. Diagnostic Laboratories
                                                                                                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                                                                                                              6. Rest of LATAM

                                                                                                                                                                                                                                                                                          Related Reports

                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                          Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
                                                                                                                                                                                                                                                                                          Buy Now

                                                                                                                                                                                                                                                                                          Purchase Benefits

                                                                                                                                                                                                                                                                                          • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                          • Completely customizable scope
                                                                                                                                                                                                                                                                                          • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                          • Dedicated account manager
                                                                                                                                                                                                                                                                                          • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                          • Permission to print the report

                                                                                                                                                                                                                                                                                          We are featured on :

                                                                                                                                                                                                                                                                                          www.straitsresearch.com
                                                                                                                                                                                                                                                                                          © Copyright . All rights Reserved.